Archive for the ‘Lyme’ Category

What Does a Lyme Rash Look Like?

https://danielcameronmd.com/what-does-a-lyme-disease-rash-look-like/  Podcast Here

WHAT DOES A LYME DISEASE RASH LOOK LIKE?

what does a lyme disease rash look like

Welcome to another Inside Lyme Podcast. I am your host Dr. Daniel Cameron. In this episode, I will be discussing a question I’m asked frequently: What does a Lyme disease rash look like? As a new study has found, the erythma migrans rash can appear differently based on several factors.

The study by Rebman and colleagues, entitled “The presenting characteristics of erythema migrans vary by age, sex, duration, and body location,” was published in Infection in March 2021.¹ It addressed a frequently asked question: What does a Lyme disease rash look like?

The erythema migrans (EM) rash (or Bull’s-eye rash), considered a definitive sign of Lyme disease, is often mistakenly thought to appear similar in all individuals – a circular red lesion which expands to at least 2 inches.

But as Rebman and colleagues report, a Lyme disease rash can look different based on several factors and does not always appear as the familiar Bull’s-eye rash. In fact, the authors suggest that relying solely on a Bull’s-eye appearance, when evaluating a rash for possible Lyme disease can lead to delays in diagnosis and treatment.

Diverse characteristics of Lyme disease rash

The authors examined 271 Lyme disease patients who had an erythema migrans rash to determine what does a Lyme disease rash look like? ¹

“We studied associations between these presenting characteristics [of EM rashes], as well as whether they were associated with age, sex, EM duration, body location, and initiation of antibiotics,” the authors write.

The patients were part of a longitudinal cohort study from 3 sites in Maryland and southeastern Pennsylvania. They were not enrolled if their rash was under 5 cm in diameter (2 inches) or their acute illness was longer than 3 months.

The study found that:

  • EM size increased over time with the EM duration peaking at 14 days.
  • Males had larger rashes than females (an average of 2.8 cm larger).
  • Males were more likely to have a blue/red rash. In fact, the odds of a red rash in males was 65% lower than in females.
  • Age was a significant predictor of central clearing. For every 10-year increase in age, the odds of central clearing decreased 25%. As age increased, there was a greater likelihood of a solid rash.
  • EM rashes were more likely to occur in harder to see body locations (i.e.,  behind the thigh and behind the knees). The authors assumed that ticks had an opportunity to attach longer in these areas before being discovered.
  • Nearly 1 in 3 patients had multiple rashes on examination.
  • Approximately 1 in 3 patients reported pain at the site of the rash.  
  • Just over 50% of the EM rashes were itchy.
  • Rash shapes were varied ─ 50.9% were round; 39.1% were oval. The remaining rashes were irregular.
  • Rash colors were varied ─ about 3 out of 4 were red. The remaining rashes were blue/red.
  • Rash patterns were varied ─  only 28% appeared as a Bull’s-eye rash (a ring within the rash). Central lightness (17.3%), central darkness (28.8%) and uniform rashes (25.8%) were also described.
  • Over 90% of the rashes were homogeneous. The remaining rashes were uneven.
  • Nearly 9% presented with vesicles. 

Concerns with limiting size of Lyme disease rash

The authors raised concerns with following a 5 cm (or less than 2 inches) cutoff for EM rashes in determining the presence of a Lyme disease infection.

“Applying a 5 cm size cutoff in research or surveillance settings may thus exclude a higher proportion of females with otherwise suggestive clinical histories and epidemiological risk,” the authors write.

They also raised concerns about recognizing an EM rash in darker skinned patients. “95.9% of our final sample self-identified as non-Hispanic white.”

The authors suggest that the variation in EM rash presentations in males vs. females and among various ages may be related to an immune response to the Borrelia infection.

Authors’ Conclusion

“Given that EM remains a clinical diagnosis, it is essential that both physicians and the general public are aware of its varied manifestations.”

Editor’s note

Unfortunately, fewer than half of Lyme disease patients present with an erythema migrans rash. This case series merely reflects the diversity of rashes in Lyme disease patients fortunate enough to present with a rash.

The following questions are addressed in this episode:

  • What is an erythema migrans rash?
  • How often do Lyme disease patients have an erythema migrans rash?
  • Can you culture Lyme disease from a rash?
  • How long do erythema migrans rashes last?
  • What other rashes resemble an erythema migrans rash?
  • What color rashes have you seen?
  • Where are rashes located?
  • What is the significance of multiple rashes on examination?
  • Have you seen itchy erythema migrans rashes?
  • Can you discuss diversity of erythema migrans rashes that were described?
  • Could a rash less than 2 inches in diameter be important?
  • What do we know about the appearance of rashes in people of color?
  • What is the importance of a smaller rash in women?

    Thanks for listening to another Inside Lyme Podcast. You can read more about these cases in my show notes and on my website @DanielCameronMD.com. As always, it is your likes, comments, reviews, and shares that help spread the word about Lyme disease. Until next time on Inside Lyme.

Please remember that the advice given is general and not intended as specific advice to any particular patient. If you require specific advice, then please seek that advice from an experienced professional.

Inside Lyme Podcast Series

This Inside Lyme case series will be discussed on my Facebook page and made available on podcast and YouTube.  As always, it is your likes, comments, and shares that help spread the word about this series and our work. If you can, please leave a review on iTunes or wherever else you get your podcasts.

To be clear, having the EM rash is diagnostic for Lyme. You are infected. On the other hand, NOT having the rash doesn’t mean you aren’t infected.

Also, EM rashes wax and wane despite treatment. Treating the EM rash is illogical because borrelia becomes systemic (all over the body) within hours. It means nothing if the EM rash disappears. This is why it’s critical to get to a Lyme literate doctor (LLMD) who is educated on such matters.

Lyme & Sudden Hearing Loss

https://danielcameronmd.com/lyme-disease-triggers-hearing-loss/

LYME DISEASE AND SUDDEN ONSET HEARING LOSS

lyme-disease-sudden-onset-hearing-loss

An article by Sowula and colleagues, published in the Journal of Clinical Medicine, describes nine patients with Lyme disease who had sudden sensorineural hearing loss (SSNHL), also referred to as sudden deafness.[1]

The study aimed to assess the prevalence of this type of sudden onset hearing loss, particularly among Lyme disease patients. The authors explain, “Sudden sensorineural hearing loss (SSNHL) is defined as sensorineural hearing loss of 30 dB or more over at least three adjacent audiometric frequencies occurring within a 72-h period of time.”

This type of sudden onset hearing loss can be caused by a viral infection, vascular insufficiency, autoimmune disorder, neoplasm, stroke and irradiation. 

Treatment is directed towards the cause with standard therapy typically involving corticosteroid, vasodilators, and ionotropic agents, the authors write. Unfortunately, the cause is unknown in 90% of the cases.

The study looked at 86 patients who were hospitalized, between 2017 and 2018, due to sudden sensorineural hearing loss. As part of their evaluation for sudden onset hearing loss, patients were tested for Lyme disease.

Out of 86 patients, 9 tested positive for Lyme disease. Other studies, however, indicate that up to 21% of patients with sudden sensorineural hearing loss test positive for Lyme disease, the authors write.

Hearing loss patients with Lyme disease

On average, the 9 patients were around 47 years old, with an age range between 30 and 70. None of the Lyme disease patients responded to intravenous corticosteroids, microcirculatory drugs, or ionotropic drugs.

Seven of the nine patients with sudden onset sensorineural hearing loss were treated with oral doxycycline or intravenous ceftriaxone.  

Four patients were treated with doxycycline. Hearing improved by 10dB for one of the patients.

Complete hearing recovery with IV ceftriaxone

The remaining 3 patients, who were treated with intravenous ceftriaxone, had complete improvement in their hearing loss.  

“Those three patients reported a complete recovery of hearing (PTA shows respectively 15.20 dB HL for low frequency and 28.35 dB HL for high frequency),” the authors write.

“Infections caused by Borrelia burgdorferi may contribute to the development of inflammatory and angiopathic lesions, which are a possible cause of [sudden sensorineural hearing loss].”

Unfortunately, 2 patients were left with high-frequency tinnitus. “In these patients, tinnitus was present from the beginning of the disease,” the authors write.

The group of 9 Lyme disease patients “was treated with antibiotics and experienced partial or complete regression of their deafness,” the authors conclude. “This may suggest a relationship between [sudden sensorineural hearing loss] and Lyme disease.”

“The longer the duration of the infection, the greater the likelihood of permanent and irreversible changes in the vessels of the cochlea or auditory nerve,” the authors caution.

References:
  1. Sowula K, Szaleniec J, Stolcman K, Ceranowicz P, Kocon S, Tomik J. Association between Sudden Sensorineural Hearing Loss and Lyme Disease. J Clin Med. Mar 8 2021;10(5)doi:10.3390/jcm10051130

___________________

For more:

Petitions to Investigate the CDC

Over 55,327 emails have been sent to key congressional committee members regarding the need for an investigation into the CDC’s death certificate data disaster and 41,201 names have been placed on our petitions to urge assistant U.S. attorneys nationwide to convene a special independent grand jury investigation into the CDC’s conduct during COVID-19.

With each passing week, it continues to become clear that an investigation—free of conflict-of-interests—into the CDC’s conduct surrounding COVID-19 is desperately needed. Here is how you can help, now!

1️⃣  Learn The Latest
Stand for Health Freedom Executive Director and Co-founder Leah Wilson recently interviewed Dr. Henry Ealy, lead author on five research papers about COVID-19 related to public health policies. His COVID Research Team has dedicated more than 20,000 hours to investigating all aspects of COVID-19, with the aim of their findings being used to empower advocates like you as well as elected officials, attorneys, professional organizations, and the general public to make informed decisions and to take action!

Thanks to Dr. Ealy and his team, Stand for Health Freedom, has solid evidence that the official COVID numbers being reported are not accurate. Moreover, these numbers have been skewed to incite fear and invoke public policies that have radically changed how we as a society work, worship, learn, move about society and interact with others, including our own family members. The United States has been in a state of public health emergency for well over a year now. We cannot idly sit by and allow agencies that are entrusted with protecting our health to invoke bad policies, keep us in a state of perpetual lockdown, or engage in acts of potential willful misconduct at the expense of our basic human rights.

2️⃣  Use Your Voice

Your voice matters—get inspired to talk to your family members, neighbors and community about the irrefutable truth that is surfacing each week alongside the questionable motives emerging; ask critical questions, share published research and invite them to watch the peer-reviewed and published experts that the mainstream media willfully ignores.

3️⃣  Easy Steps You Can Take
Take a stand and call upon U.S. Attorneys and key members of Congress to investigate the CDC’s conduct.

✔️ Step One: Take Action by adding your signature today to join our petition to call on key U.S. Attorneys to investigate the CDC’s conduct through a formal Grand Jury investigation.

https://standforhealthfreedom.com/action/cdc-grand-jury-investigation/ Sign here

✔️ Step Two: Take Action by sending a letter to ask members of Congress to formally investigate the CDC’s conduct during COVID-19 through congressional hearings.

https://standforhealthfreedom.com/action/investigate-the-cdc/  Sign here

“It is incumbent upon you to do your homework and be a part of your own rescue because the people who are in positions of power right now are abusing their power. They are corrupt, and they do not have our families and our children’s best interests at heart. And their actions prove it over and over again, regardless of the lies they continue to spill out of their mouths. … We cannot protect our children by being polite and silent about this anymore. It is incumbent upon us to be the shield that protects our families, and the way we do that is through knowledge and love.”– Dr. Henry Ealy

In Solidarity

Stand for Health Freedom

P.S. Dr. Ealy appeared in Stand for Health Freedom’s CDC Data Disaster panel event this past February, where a panel of experts discussed why we should be concerned about death certificate data, why accuracy, integrity and transparency are so important during a public health crisis, how the CDC set the stage for widespread devastation — physical, psychological and economic, and some simple steps we can take so that incidents of this magnitude never happen again.

P.S.S. Support our efforts in growing the health freedom voting bloc by donating here.

____________________

For Stand for Freedom’s Peer-Reviewed position paper & petition to investigate the CDC, go here.

Please also sign Lyme advocate Carl Tuttle’s petition to investigate the CDC over the mismanagement of Lyme/MSIDS:   https://madisonarealymesupportgroup.com/2019/04/23/cdcs-long-history-of-incompetence-deception-in-the-management-of-lyme-disease/

For more:

Lyme Disease, Autoimmune Encephalopathy, & Basal Ganglia Encephalitis

http://  Approx. 1 hour, 15 Min.

Nov. 23, 2020

The Links between Lyme Disease and Autoimmune Encephalopathy and Basal Ganglia Encephalitis (BGE) – Presentation and Q&A Part of the PANS/PANDAS webinar series
Professor Craig Shimasaki,
CEO of Moleculera Labs,
Oklahoma USA Presentation

Why So Many Are Misdiagnosed With MS & Lyme

https://www.bitchute.com/video/n6mUXJeyYqdg/  Video Here, Approx. 30 Min

DR. KENNETH STOLLER ON WHY SO MANY ARE MISDIAGNOSED WITH MULTIPLE SCLEROSIS & LYME DISEASE

For more with Dr. Stoller: